GL1X · GenesisL1 explorer

Research workbench

Golgi alpha-mannosidase II D341N mutant complex with 5-F-guloside

Analyse Golgi alpha-mannosidase II D341N mutant complex with 5-F-guloside in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1QWU
Type
protein
Length
1,014 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-mannosidase II
EC
3.2.1.114
UniProt
Q24451
Ligands
GUL, NAG, ZN
Pockets
14 · best druggability 0.80

Structure

x-ray diffraction · 1 distinct chain · 24% helix, 30% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AAlpha-mannosidase II (EC 3.2.1.114)protein101424% helix, 30% strandQ24451

Ligands and binding sites

  • GUL · (2R,3S,4R,5S)-2,6-difluoro-2-(hydroxymethyl)oxane-3,4,5-triol · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · chains A
  • ZN · Zinc ion · metal · chains A
  • MPD · (4S)-2-methyl-2,4-pentanediol · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 5 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11300.800.9830empty
22270.770.9142empty
34690.700.8072empty
42640.620.8131empty
52340.520.7631GUL

Modifications

Observed in the structure: 5 disulfide, 1 covalent, 1 glycan (disulfide, covalent ligand, N-glycosylation).

Compared structures

  • 1QWU · Golgi alpha-mannosidase II D341N mutant complex with 5-F-guloside · the same entry in another collection · chain A against A, TM-score 1.00
  • Q24451 · AlphaFold monomer V2.0 prediction for alpha-mannosidase 2 (Q24451) · a predicted model of the same protein · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.